BCL2L11 and hepatocellular carcinoma: In hepatocellular carcinoma (HCC), MALAT1-upregulated SRSF1 enhances the isoforms of the antiapoptotic gene BIM and the oncogenes S6K1 and TEAD1, leading to cancer cell proliferation, survival, and tumorigenesis [37].